Heart Test Laboratories Accounts Payable

Heart Test Laboratories (HSCS) currently reports a accounts payable of $1M as of July 2026. That compares with $280M in the prior-year period — down 99.6% year over year. Use the charts on this page to explore Heart Test Laboratories's accounts payable history and peer comparisons.

Heart Test Laboratories's accounts payable decreased from $280M to $1M — a 99.6% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Heart Test Laboratories reported $1M in accounts payable as of July 2026. That compares with $280M in the prior-year period — down 99.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Heart Test Laboratories, and consider following HSCS for alerts when major investors trade the stock.